Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis Announces Valedia Key Data

Oct 3 (Reuters) - VALBIOTIS SAS  ALVAL.PA :
    * VALBIOTIS - VALEDIA®: KEY DATA SUPPORTING THE SUBMISSION
OF A
HEALTH CLAIM, SELECTED AND PRESENTED AT THE EASD 54TH CONGRESS
IN BERLIN
    * DATA OBTAINED IN CLINICALLY RELEVANT MODELS, RELATIVE TO
MECHANISM OF ACTION
    * NEW RESULTS, INCLUDING A MAINTAINED SECRETION OF INSULIN
BY
PANCREAS,
    * IN VIVO CHARACTERISATION OF MULTI-TARGETED MECHANISM OF
ACTION
SHOWN TO IMPACT 5 KEY ORGANS

Source text for Eikon:  ID:nBw38FG3Ja 
Further company coverage:  ALVAL.PA 

 (Gdynia Newsroom:)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Valbiotis SA

See all news